UBS’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$1.39M Sell
20,055
-7,140
-26% -$493K ﹤0.01% 2466
2014
Q2
$1.56M Buy
27,195
+7,704
+40% +$442K ﹤0.01% 2389
2014
Q1
$772K Sell
19,491
-2,879
-13% -$114K ﹤0.01% 2836
2013
Q4
$938K Buy
22,370
+3,178
+17% +$133K ﹤0.01% 2625
2013
Q3
$572K Hold
19,192
﹤0.01% 2851
2013
Q2
$1.02M Buy
+19,192
New +$1.02M ﹤0.01% 2382